Edifier MR4 Powered Studio Monitor 2.0 Speakers 42 Watts (White)

Product Information

a b "Ministry of Defence; The Major Projects Report 2010" (PDF). National Audit Office. 15 October 2010 . Retrieved 14 June 2010. Enter the single numeric code for the type of guarantee used. A list of codes is found in annex B of EU 2015/2447. For goods under TIR, select code ‘B’. The Major Projects Report 2010". National Audit Office. 15 October 2010. Archived from the original on 5 August 2011 . Retrieved 12 November 2010. Patients who achieved sMR4 reached sMR3 more rapidly (median 12.3 months, range: 1-135.2) than those whose best response was sMR3 only (median 24.5 months, range: 2.8-184.4; P<0.001). The median follow up of patients in sMR3 only was shorter (56.9 months, range: 12.3-155) than those in sMR4 (108.1 months, range: 14.6-199.7).

Alikian M, Ellery P, Forbes M. Nextgeneration sequencing-assisted DNA-based digital PCR for a personalized approach to the detection and quantification of residual disease in chronic myeloid leukemia patients. J Mol Diagn. 2016; 18(2):176-189. https://doi.org/10.1016/j.jmoldx.2015.09.005 PubMed Google Scholar Hochhaus A, Saglio G, Hughes TP. Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial. Leukemia. 2016; 30(5):1044-1054. https://doi.org/10.1038/leu.2016.5 PubMed PubMed Central Google ScholarAn Authorised Consignee need not present the goods at the office of destination, but at an authorised location, which can be: To be used only under Normal Procedure, when the declaration is being pre-lodged. Use of this field will result in the declaration being placed in the submitted state. The MRN will not be issued until a Customs Officer at the office of departure ‘accepts’ the declaration electronically. Branford S, Seymour JF, Grigg A. BCRABL messenger RNA levels continue to decline in patients with chronic phase chronic myeloid leukemia treated with imatinib for more than 5 years and approximately half of all first-line treated patients have stable undetectable BCR-ABL using strict sensitivity criteria. Clin Cancer Res. 2007; 13(23):7080-7085. https://doi.org/10.1158/1078-0432.CCR-07-0844 PubMed Google Scholar New Computerised Transit System ( NCTS) became mandatory for Transports Internationaux Routiers ( TIR) declarations from 1 January 2008. An Authorised Consignor need not present the goods at the office of departure, but at an authorised location, which can be:

Ross DM, Branford S, Seymour JF. Patients with chronic myeloid leukemia who maintain a complete molecular response after stopping imatinib treatment have evidence of persistent leukemia by DNA PCR. Leukemia. 2010; 24(10):1719-1724. https://doi.org/10.1038/leu.2010.185 PubMed Google Scholar Ross DM, Branford S.. Minimal residual disease: the advantages of digital over analog polymerase chain reaction. Leuk Lymphoma. 2011; 52(7):1161-1163. https://doi.org/10.3109/10428194.2011.580481 PubMed Google Scholar Kantarjian HM, Shah NP, Cortes JE. Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2- year follow-up from a randomized phase 3 trial (DASISION). Blood. 2012; 119(5):1123-1129. https://doi.org/10.1182/blood-2011-08-376087 PubMed PubMed Central Google Scholar To test the Edifier MR4 studio monitors, I spent a week with them, listening to various genres of music, watching various streaming video, and playing computer games on them. While testing, I used them at different volumes to see how that affected the sound quality.Required if not completed at header level. Use the header level consignor field when only one consignor is declared. Enter the nationality of the Means of Transport declared at departure. Refer to the List of Country Codes in Part 1 of the Tariff. Box 18 may be omitted in certain circumstances with the details subsequently recorded in Box 55. Enter the guarantee reference number in this field if the ‘guarantee type’ field contains the code ‘0’, ‘1’, ‘2’, ‘4’ or ‘9’. A customs sub place is ‘any place designated, approved and controlled by a customs office of departure or destination for the presentation and examination of goods, for the purpose of commencing or ending a transit movement at that office’.

Treatment-free survival (TFS) in chronic myeloid leukemia (CML) is a new goal. This prospective study aims to evaluate imatinib discontinuation's feasibility and safety in patients with deep molecular response MR4 (BCR-ABL1 < 0.01 % IS). Hoyle, Craig. "RAF launches first Nimrod MRA4 training course." Flight International, 4 August 2010. Jennings LJ, George D, Czech J, Yu M, Joseph L.. Detection and quantification of BCR-ABL1 fusion transcripts by droplet digital PCR. J Mol Diagn. 2014; 16(2):174-179. https://doi.org/10.1016/j.jmoldx.2013.10.007 PubMed Google Scholar Enter the code for the active Means of Transport, which, it is expected, will be used, on exit from the customs territory of the Union. Codes are: 1=Sea, 2=Rail, 3=Road, 4=Air, 5=Post, 7=Fixed transport installation, 8=Inland waterway and 9=Own propulsion.Enter the code in the format ‘2a country+6nOffice identifier’ for example, IT071100. The complete list is available at Common and Union transit - European Commission. Mahon F, Boquimpani C, Kim D. Treatment-free remission after second-line nilotinib treatment in patients with chronic myeloid leukemia in chronic phase: results from a single-group, phase 2, open-label study. Ann Intern Med. 2018; 168(7):461-470. https://doi.org/10.7326/M17-1094 PubMed Google Scholar Merx K, Muller MC, Kreil S. Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of interferon alpha. Leukemia. 2002; 16(9):1579-1583. https://doi.org/10.1038/sj.leu.2402680 PubMed Google Scholar